Clinical Trial Update: Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lipoic acid for chronic inflammatory demyelinating polyneuropathy (CIDP) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Lipoic acid (alpha-lipoic acid)

Snippet

Sponsor: Oregon Health and Science University | Conditions: CIDP, Chronic Inflammatory Demyelinating Polyneuropathy | Phase 2 | Status: COMPLETED | Results posted: 2020-08-19